DK0931087T3 - Nye pyranosidderivater - Google Patents

Nye pyranosidderivater

Info

Publication number
DK0931087T3
DK0931087T3 DK97944867T DK97944867T DK0931087T3 DK 0931087 T3 DK0931087 T3 DK 0931087T3 DK 97944867 T DK97944867 T DK 97944867T DK 97944867 T DK97944867 T DK 97944867T DK 0931087 T3 DK0931087 T3 DK 0931087T3
Authority
DK
Denmark
Prior art keywords
new
pyranoside
derivatives
pyranoside derivatives
new pyranoside
Prior art date
Application number
DK97944867T
Other languages
Danish (da)
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Franz Birke
Hans Michael Jennewein
Christopher John Montagu Meade
Andreas Ding
Ernst-Otto Renth
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0931087T3 publication Critical patent/DK0931087T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97944867T 1996-09-12 1997-09-10 Nye pyranosidderivater DK0931087T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637123A DE19637123A1 (de) 1996-09-12 1996-09-12 Neue Pyranosidderivate
PCT/EP1997/004948 WO1998011119A1 (fr) 1996-09-12 1997-09-10 Nouveaux derives de pyranoside

Publications (1)

Publication Number Publication Date
DK0931087T3 true DK0931087T3 (da) 2002-07-01

Family

ID=7805404

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944867T DK0931087T3 (da) 1996-09-12 1997-09-10 Nye pyranosidderivater

Country Status (16)

Country Link
EP (1) EP0931087B1 (fr)
JP (1) JP4215278B2 (fr)
AR (1) AR009769A1 (fr)
AT (1) ATE215551T1 (fr)
AU (1) AU4622597A (fr)
CA (1) CA2263846C (fr)
DE (2) DE19637123A1 (fr)
DK (1) DK0931087T3 (fr)
ES (1) ES2174297T3 (fr)
HR (1) HRP970487A2 (fr)
ID (1) ID18262A (fr)
PE (1) PE107398A1 (fr)
PT (1) PT931087E (fr)
WO (1) WO1998011119A1 (fr)
YU (1) YU37597A (fr)
ZA (1) ZA978086B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141654A0 (en) * 1998-09-04 2002-03-10 Byk Gulden Lomberg Chem Fab Pyranose derivatives and pharmaceutical compositions containing the same
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
JP2004523512A (ja) * 2001-01-16 2004-08-05 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ムチン遺伝子の増大された発現により生じる疾患の治療及び／又は予防のためのｌｔｂ４アンタゴニストの使用
RU2004102399A (ru) * 2001-07-14 2005-05-27 Берингер Ингельхайм Фарма Гмбх Ко.Кг (De) Лекарственная композиция, содержащая ltb4-антагонист
EP3383388B1 (fr) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
WO2017095724A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
EP3383869B1 (fr) 2015-11-30 2023-06-28 Merck Sharp & Dohme LLC Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
WO2017095723A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
US20200199168A1 (en) * 2017-05-12 2020-06-25 Riken Class a gpcr-binding compound modifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
ES2165122T3 (es) * 1992-02-05 2002-03-01 Boehringer Ingelheim Pharma Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CA2263846A1 (fr) 1998-03-19
DE59706897D1 (de) 2002-05-08
PE107398A1 (es) 1999-02-03
AR009769A1 (es) 2000-05-03
EP0931087A1 (fr) 1999-07-28
YU37597A (en) 1999-11-22
ES2174297T3 (es) 2002-11-01
ATE215551T1 (de) 2002-04-15
HRP970487A2 (en) 1998-08-31
PT931087E (pt) 2002-09-30
ZA978086B (en) 1998-03-12
CA2263846C (fr) 2006-11-14
JP4215278B2 (ja) 2009-01-28
AU4622597A (en) 1998-04-02
EP0931087B1 (fr) 2002-04-03
JP2001500146A (ja) 2001-01-09
DE19637123A1 (de) 1998-03-19
WO1998011119A1 (fr) 1998-03-19
ID18262A (id) 1998-03-19

Similar Documents

Publication Publication Date Title
NO983356D0 (no) Nye 19-nor-pregnenderivater
DK0901474T3 (da) Arylpyrimidinderivater
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
NO970512D0 (no) Nye heteroaryl-oksazolidinoner
NO981946D0 (no) Imidazoquinazolin-derivater
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20003346D0 (no) Nye erytromycinderivater
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
DK0906288T3 (da) Nye forbindelser
NO960268D0 (no) Nye dialkoksypyridinylbenzimidazolderivater
DK0931087T3 (da) Nye pyranosidderivater
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
BR9507892A (pt) Novos derivados de diamino-metilideno
NO990072D0 (no) Nye forbindelser
NO991096D0 (no) Nye fremgangsmÕter
NO992302L (no) Piperidin-derivater
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
NO993171D0 (no) Substituerte propionylderivater
DK0946548T3 (da) Nye heterocykliske substituerede pyrrolidinamidderivater
BR9706980A (pt) Derivados de isooxacefem
BR9708310A (pt) Derivados de 2-tioxotetrahidropirimidin-4-ona
NO983505D0 (no) Nye fenantrider
DK0886645T3 (da) Nye 19-nor-pregnen-derivater
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate